Torti Frank 4
4 · Immunovant, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Torti Frank
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-01+93,599→ 93,599 totalExercise: $15.20Exp: 2035-04-01→ Common Stock (93,599 underlying) - Award
Common Stock
2025-04-01+199,365→ 835,039 total
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- [F2]The shares underlying the options will vest in substantially equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date.